The HR for death was 0.4164 (95% CI: 0.1613–1.075), indicating a strong trend toward increased mortality in TP53-mutated AML.
← all excerpts
Genomic and clinical determinants of outcome in Irish AML: a real-world analysis (2007-2025), single centre experience.
1
—
—